1. Home
  2. EVN vs RZLT Comparison

EVN vs RZLT Comparison

Compare EVN & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Municipal Income Trust

EVN

Eaton Vance Municipal Income Trust

HOLD

Current Price

$9.82

Market Cap

414.0M

Sector

Finance

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$3.71

Market Cap

471.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVN
RZLT
Founded
N/A
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
414.0M
471.0M
IPO Year
1998
2011

Fundamental Metrics

Financial Performance
Metric
EVN
RZLT
Price
$9.82
$3.71
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $9.80
AVG Volume (30 Days)
231.2K
★ 1.7M
Earning Date
01-01-0001
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 23.47
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,214.20
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.00
$1.07
52 Week High
$11.26
$11.46

Technical Indicators

Market Signals
Indicator
EVN
RZLT
Relative Strength Index (RSI) 53.16 38.22
Support Level $9.00 $3.69
Resistance Level $10.85 $4.09
Average True Range (ATR) 0.18 0.37
MACD 0.09 -0.07
Stochastic Oscillator 90.00 22.40

Price Performance

Historical Comparison
EVN
RZLT

About EVN Eaton Vance Municipal Income Trust

Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.

Share on Social Networks: